Next, downregulation of ZCCHC4 leads to increased sensitivity of ESCC cells to cisplatin, suppression of cell viability, a reduction in the S phase of the cell cycle, and the induction of apoptosis in esophageal cancer cells. Here, ZCCHC4 is linked to esophageal squamous cell carcinoma.